Cancer
Researchers from the Mayo Clinic have made a groundbreaking discovery in the field of cancer gene therapy. By leveraging preexisting anti-viral memory responses, they have found a way to focus high-affinity T cell responses into tumors, leading to cancer cures. This innovative approach utilizes oncolytic viruses or chimeric antigen receptors
Cancer
Researchers from Jamia Hamdard University have discovered that CD4 T-cells play a crucial role in cancer immunology, and novel drug delivery systems, particularly nanoparticle-based formulations, can enhance antitumor immune responses while minimizing systemic toxicity. The study aimed to explore the immunological significance of CD4 T-cells in cancer and their modulation
Cancer
A study published in the Turkish Journal of Surgery investigated the relationship between muscular atrophy, sarcopenia, and postoperative outcomes in patients with gastric cancer. Researchers from Marmara University found that patients with sarcopenia and myosteatosis, a condition characterized by low muscle density, had poorer surgical outcomes and shorter overall survival
Cancer
Researchers at Hokkaido University in Sapporo, Japan, have made a crucial discovery regarding the effects of radiation therapy on cancer cell migration. According to their study, published in the International Journal of Molecular Sciences, radiation-induced bystander effects can inadvertently enhance tumor cell motility outside the target volume. This finding has
Cancer
Advanced sarcomas, a rare and aggressive type of cancer, have limited treatment options. Researchers from Shandong Cancer Hospital in China investigated the efficacy and safety of combining sintilimab and anlotinib, two immunotherapies, in treating advanced sarcomas. The study involved 42 patients with untreated or chemotherapy-resistant sarcomas. The combination treatment resulted
Cancer
Researchers at Tianjin Medical University General Hospital have reported a potential immunotherapeutic target for gastric cancer, revealing a novel role of EBI3 in promoting CD8+ T cell exhaustion and compromising the effectiveness of immunotherapy. The study highlights the correlation between EBI3 expression levels and clinical-pathological features of gastric cancer, including
Cancer
Gastric cancer remains one of the most common and deadly cancer types worldwide. Researchers from the Federal University of Sao Paulo have identified two minimally invasive biomarkers in peripheral blood that can be used for gastric cancer detection and postoperative monitoring. The study, published in In Vivo, found that expression
Cancer
Researchers at Cedars-Sinai Medical Center have highlighted the challenges in using CAR-T cell therapy for treating solid tumors, including the unique immune microenvironment of these tumors. The study emphasizes the need for optimizing CAR-T cell functionality and adaptability to improve the therapy's effectiveness. Specifically, the research focuses on
Cancer
Research investigators have developed new antibody-gamma delta (gd) T cell conjugates that hold great promise in adoptive cell therapy, a promising approach to cancer treatment. The new conjugates are designed to enhance tumor-targeting efficiency and induce cancer cell pyroptosis. A team of researchers from Peking University conducted the study, which
Cancer
Research findings on artificial intelligence (AI) and machine learning (ML) applications in cancer immunotherapy have made significant progress in addressing the complex interplay between cancer and the immune system. A new report from the City of Hope National Medical Center in Duarte, California, highlights the potential of AI technologies in
Cancer
Recent research on diagnostics and screening for cancer has made significant strides in identifying key regulators of gene expression and cellular signaling in cancer. Long non-coding RNAs (lncRNAs) are increasingly recognized as crucial modulators of chromatin structure, epigenetic remodeling, transcription, and signal transduction. A team of researchers from St. John&
Cancer
Researchers at the Indiana University School of Medicine have made a significant breakthrough in cancer treatment by reprogramming regulatory T cells (Tregs) to enhance antitumor immunity. According to a study published in Science Immunology, shifting the expression of FOXP3 from its full-length isoform to a short isoform with exon 2
